Alan D. Brooks

ORCID: 0000-0002-4666-1934

MedicineBiochemistry, Genetics and Molecular BiologySocial SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins”.

Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins

Cancer Research(2021)10.1158/0008-5472.can-20-2634

N/A

0DataRank · unranked

14 citations

Alan D. Brooks, Ya-ming Xu, E. M. Kithsiri Wijeratne, Ashley L. Babyak, Timothy Back +11 more

Implementing the immunization agenda 2030: A framework for action through coordinated planning, monitoring & evaluation, ownership & accountability, and communications & advocacy

Vaccine(2023)10.1016/j.vaccine.2021.09.045

N/A

0DataRank · unranked

41 citations

Eric E. Mast, Sarah Churchill, Nargis Rahimi, Jan Grevendork, Alan D. Brooks +4 more

Data from Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins

(2023)10.1158/0008-5472.c.6513079.v1

N/A

0DataRank · unranked

0 citations

Alan D. Brooks, Ya-ming Xu, E. M. Kithsiri Wijeratne, Ashley L. Babyak, Timothy Back +11 more